1-{2-[(3,5-dimethylphenyl)amino]-2-oxoethyl}piperidine-4-carboxylic acid, 95.0%, 500mg

4-Morpholinopyridin-3-amine, 95.0%, 100mg

5-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrrolo[2,3-b]pyridine, 98%, 250mg

3-(DIFLUOROMETHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE, 95.0%, 1g

4-Methyl-2-oxo-2H-chromen-7-yl stearate, 97%, 100mg

(S)-BINAP, min. 98%, 250 mg, glass packaging

N2,N7-Dicyclohexyl-9-(hydroxyimino)-9H-fluorene-2,7-disulfonamide, 250mg

tert-Butyl but-3-enoate, 95%, 25g

Bicyclo[1.1.1]pentan-1-amine Hydrochloride>98.0%(GC)(T)200mg

(Z)-7-[(2S)-2-AMINO-3-HYDROXY-3-OXOPROPYL]SULFANYL-2-[[(1S)-2,2-DIMETHYLCYCLOPROPANECARBONYL]AMINO]HEPT-2-ENOIC ACID, 95.0%, 250mg

4-Methoxy-2-nitrophenol>98.0%(GC)(T)25g

4-Hydroxycyclopent-2-enone, 97.0%, 250mg

5,7-Dichloro-3-methyl-3H-imidazo[4,5-b]pyridine, 95%, 100mg